GLP-1–Based Therapies Significantly Reduce Inflammation in Cardiometabolic Disease: Meta-Analysis

China: Research presented at the International Congress on Obesity showed that incretin-based therapies (GLP-1 receptor agonists) significantly lower high-sensitivity C-reactive protein (hs-CRP), a...
Read the full report on Business Medical Dialogues
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Business Medical Dialogues
- Reporter
- medha baranwal
- Published
- Saturday, 10 October 2026, 9:15 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Business Medical Dialogues with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

